Alvin S. Parven, Director at ALEXION PHARMACEUTICALS INC (ALXN), sold 895 shares at $178.73 ($160K) on 2015-11-02, disclosed to the SEC on 2015-11-04.
Seasonal sale ($160k) by Director — this insider has traded ALXN in November in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ALXN | SELL | 2016-08-24 | $2.1M | — | Filing → |
| ALXN | SELL | 2014-11-13 | $2.9M | — | Filing → |
| ALXN | SELL | 2014-05-15 | $2.0M | — | Filing → |